The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...
The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...
Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.
Dawn Klemow, MD, assistant clinical professor, University of Texas Southwestern Medical Center, previews some of the most recent advances in breast cancer treatment.
Breast Cancer Now said olaparib will be an ‘valuable alternative’ for patients with a certain type of secondary breast cancer ...
Cancer diagnoses are expected to exceed two million in 2025, with approximately 618,120 deaths predicted, according to the ...
Cancer researchers at the University of Leicester have developed a technique that could predict how well some breast cancer ...
Although long considered a disease of aging, certain cancers are turning up more often in younger women, according to a new ...
Researchers at Case Western Reserve University School of Medicine have discovered how specific protein regions contribute to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback